Trial Profile
The study of effects of paliperidon extended-release tablets and olanzapine on metabolic profile
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Pharmacodynamics
- 22 May 2013 Status changed from recruiting to completed according to results presented at the 166th Annual Meeting of the American Psychiatric Association.
- 22 May 2013 Results presented at the 166th Annual Meeting of the American Psychiatric Association.
- 20 Jun 2012 New trial record